Upstream Bio (NASDAQ:UPB) shares rallied 32% Friday following the asthma drug developer’s $255M upsized initial public offering. Shares of Upstream (UPB) opened at $21.50, later reaching a high of $22 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results